Trademark: 90123459
Word
INBRACE SUPPORT PROGRAM
Status Date
Monday, April 25, 2022
Filing Date
Wednesday, August 19, 2020
Published for Opposition
Tuesday, July 27, 2021
Abandoned Date
Monday, April 25, 2022
35 Promoting the interests of people who have Parkinson's disease and their families and health care providers by means of public advocacy; promoting the interests of people who have Friedreich's ataxia and their families and health care providers by means of public advocacy; promoting the interests of people who have congenital birth defects and their families and health care providers by means of public advocacy; promoting the interests of people who have rare pediatric epilepsies and their families and health care providers by means of public advocacy; promoting the interests of people who have SCN8A developmental and epileptic encephalopathy and their families and health care providers by means of public advocacy; promoting the interests of people who have congenital adrenal hyperplasia and their families and health care providers by means of public advocacy; promoting the interests of people who have neurological diseases and their families and health care providers by means of public advocacy; promoting the interests of people who have central nervous system diseases and their families and health care providers by means of public advocacy; promoting the interests of people who have psychiatric diseases and their families and health care providers by means of public advocacy; promoting the interests of people who have movement diseases and their families and health care providers by means of public advocacy; promoting the interests of people who have endocrine diseases and their families and health care providers by means of public advocacy; promoting the interests of people who have hormonal diseases and their families and health care providers by means of public advocacy; promoting the interests of people who have genetic diseases and their families and health care providers by means of public advocacy
44 Providing medical information regarding pharmaceutical products and services; pharmaceutical consultation, namely, treatment support programs that coordinate insurance, drug delivery and prescription management between physicians, patients, and pharmacies; providing medical and health information in the field of Parkinson's disease; providing medical and health information in the field of Friedreich's ataxia; providing medical and health information in the field of congenital birth defects; providing medical and health information in the field of rare pediatric epilepsies; providing medical and health information in the field of SCN8A developmental and epileptic encephalopathy; providing medical and health information in the field of congenital adrenal hyperplasia; providing medical and health information in the field of neurological diseases; providing medical and health information in the field of central nervous system diseases; providing medical and health information in the field of psychiatric diseases; providing medical and health information in the field of movement diseases; providing medical and health information in the field of endocrine diseases; providing medical and health information in the field of hormonal diseases; providing medical and health information in the field of genetic diseases
42 Creating an online community for people who have Parkinson's disease and their families and health care providers for the purpose of engaging with and sharing information in the field of Parkinson's disease; creating an online community for people who have Friedreich's ataxia and their families and health care providers for the purpose of engaging with and sharing information in the field of Friedreich's ataxia; creating an online community for people who have congenital birth defects and their families and health care providers for the purpose of engaging with and sharing information in the field of congenital birth defects; creating an online community for people who have rare pediatric epilepsies and their families and health care providers for the purpose of engaging with and sharing information in the field of rare pediatric epilepsies; creating an online community for people who have SCN8A developmental and epileptic encephalopathy and their families and health care providers for the purpose of engaging with and sharing information in the field of SCN8A developmental and epileptic encephalopathy; creating an online community for people who have congenital adrenal hyperplasia and their families and health care providers for the purpose of engaging with and sharing information in the field of congenital adrenal hyperplasia; creating an online community for people who have neurological diseases and their families and health care providers for the purpose of engaging with and sharing information in the field of neurological diseases; creating an online community for people who have central nervous system diseases and their families and health care providers for the purpose of engaging with and sharing information in the field of central nervous system diseases; creating an online community for people who have psychiatric diseases and their families and health care providers for the purpose of engaging with and sharing information in the field of psychiatric diseases; creating an online community for people who have movement diseases and their families and health care providers for the purpose of engaging with and sharing information in the field of movement diseases; creating an online community for people who have endocrine diseases and their families and health care providers for the purpose of engaging with and sharing information in the field of endocrine diseases; creating an online community for people who have hormonal diseases and their families and health care providers for the purpose of engaging with and sharing information in the field of hormonal diseases; creating an online community people who have genetic diseases and their families and health care providers for the purpose of engaging with and sharing information in the field of genetic diseases
The mark consists of the stylized word "INBRACE" in teal with a circle inside of the letter "C" shaded from teal to gold above the stylized words "SUPPORT PROGRAM" in gold.
The color(s) teal and gold is/are claimed as a feature of the mark.
"SUPPORT PROGRAM"
Apr 25, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 25, 2022
Abandonment - No Use Statement Filed
Sep 21, 2021
Noa E-Mailed - Sou Required From Applicant
Jul 27, 2021
Official Gazette Publication Confirmation E-Mailed
Jul 27, 2021
Published For Opposition
Jul 7, 2021
Notification Of Notice Of Publication E-Mailed
Jun 22, 2021
Approved For Pub - Principal Register
Jun 22, 2021
Examiner's Amendment Entered
Jun 22, 2021
Notification Of Examiners Amendment E-Mailed
Jun 22, 2021
Examiners Amendment E-Mailed
Jun 22, 2021
Examiners Amendment -Written
Jun 22, 2021
Teas/Email Correspondence Entered
Jun 21, 2021
Correspondence Received In Law Office
Jun 21, 2021
Teas Response To Office Action Received
Dec 21, 2020
Notification Of Non-Final Action E-Mailed
Dec 21, 2020
Non-Final Action E-Mailed
Dec 21, 2020
Non-Final Action Written
Dec 15, 2020
Assigned To Examiner
Sep 22, 2020
Notice Of Design Search Code E-Mailed
Sep 21, 2020
New Application Office Supplied Data Entered In Tram
Aug 22, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
